Aberdeen Group plc CRNX — CRINETICS PHARMACEUTICALS IN

Ownership history in Aberdeen Group plc  ·  10 quarters on record

AI Ownership Summary

Aberdeen Group plc reported CRINETICS PHARMACEUTICALS IN (CRNX) in 10 quarterly 13F filings from 2023 Q4 through 2026 Q1. Peak portfolio weight reached 0.05% in 2025 Q4. The latest visible filing shows CRNX at 0.05% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this CRNX ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Aberdeen Group plc's position in CRINETICS PHARMACEUTICALS IN, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

CRNX was reported at 0.05% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.05% in 2025 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

CRNX stock page Aberdeen Group plc fund profile Aberdeen Group plc full holdings
How Aberdeen Group plc held CRNX — position size vs. price
% of Fund (quarterly)    CRNX price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 10 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 ADDED — — — 820,395 +145,862 +21.6% 0.05% $29.8M 2026-04-29 $38.44
2025 Q4 ADDED — — — 674,533 +334,584 +98.4% 0.05% $31.4M 2026-01-16 $55.99
2025 Q3 ADDED — — — 339,949 +59,602 +21.3% 0.02% $14.2M 2025-11-07 $40.00
2025 Q2 ADDED — — — 280,347 +72,288 +34.7% 0.01% $8.1M 2025-07-24 $30.41
2025 Q1 ADDED — — — 208,059 +164,670 +379.5% 0.01% $7.0M 2025-05-13 $30.95
2024 Q4 ADDED — — — 43,389 +7,922 +22.3% 0.00% $2.2M 2025-01-24 $38.79
2024 Q3 REDUCED 46.4% -0.8% ✅ 35,467 -30,729 -46.4% 0.00% $1.8M 2024-10-25 $57.96
2024 Q2 REDUCED 34.6% +14.1% ❌ 66,196 -35,000 -34.6% 0.01% $3.0M 2024-08-09 $47.64
2024 Q1 UNCHANGED — — — 101,196 — 0% 0.01% $4.7M 2024-05-09 $49.42
2023 Q4 INITIATED — — — 101,196 — — 0.01% $3.6M 2024-01-31 $36.48

🏢 Other funds also holding CRNX

As of 2026 Q1 — sorted by position size

MOODY ALDRICH PARTNERS LLC 3Y 7Y 1.2% BRAUN STACEY ASSOCIATES INC 3Y 7Y 0.39% Lewis Asset Management, LLC 0.39% PSP Research LLC 0.28% Candriam S.C.A. 3Y 7Y 0.16% SANDERS MORRIS HARRIS LLC 3Y 7Y 0.12% Pictet Asset Management Holding SA 0.07% China Universal Asset Management Co., Ltd. 3Y 0.05% Bayforest Capital Ltd 0.04% AlphaQuest LLC 0.04%

FAQ About Aberdeen Group plc and CRNX

These are the practical questions this page is built to answer before you even open the full history table.

How long has Aberdeen Group plc reported owning CRNX?

Aberdeen Group plc reported CRNX across 10 quarterly 13F filings, from 2023 Q4 through 2026 Q1.

What was the largest reported CRNX position in Aberdeen Group plc's portfolio?

The largest reported portfolio weight for CRNX was 0.05% in 2025 Q4.

What is the latest reported CRNX position on this page?

The most recent filing on this page is 2026 Q1, when Aberdeen Group plc reported 820,395 shares, equal to 0.05% of portfolio, with an estimated market value of $29.8M.

What does the chart on this CRNX ownership page compare?

The chart compares Aberdeen Group plc's quarterly CRNX portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Aberdeen Group plc time their CRNX position?

Based on 13F filing dates vs. subsequent CRNX price moves, Aberdeen Group plc correctly timed 4 out of 8 reported position changes (50%). The annualised alpha on CRNX relative to SPY over the holding period was -14.9%.

← Back to Aberdeen Group plc Holdings